Where does Rudy Dekeyser work?

Rudy Dekeyser is Partner at EQT Life Sciences.

What does Rudy Dekeyser invest in?

Rudy Dekeyser invests in Biotech.

What check size does Rudy Dekeyser write?

Rudy Dekeyser typically writes checks of $11M – $65M.

What boards does Rudy Dekeyser sit on?

Rudy Dekeyser holds tracked board seats at Lumeon.

Where did Rudy Dekeyser go to school?

Rudy Dekeyser studied at Ghent University (Doctor of Philosophy - PhD, Agriculture Biotechnology).

Rudy Dekeyser

Investor

Partner at EQT Life Sciences

Belgium

Writes $11M – $65M checks · typically $25M

About

Head of the Health Economic Funds at EQT Life Sciences and Partner at EQT since 2022; previously a Partner at LSP (2012-2022, which became EQT Life Sciences), Managing Director at VIB in Belgium leading business development, and senior advisor at IWT. Holds a PhD in biotechnology from the University of Ghent.

Contact· self-published, not guessed

r•••@eqtpartners.comreveal

Invests in

Biotech

Experience

EQT GroupPartnercurrent2012 — presentAmsterdam, North Holland, Netherlands
Nobi Smart LampsMember Board of Directorscurrent2022 — presentBelgium
LumeonMember Board of Directorscurrent2018 — presentGreater London, England, United Kingdom
Stichting De WeijerhorstMember Board of Directorscurrent2018 — presentNetherlands
Anticancer FundMember Board of Directorscurrent2022 — presentBelgium
Foundation GénéretMember of the Board of Advisorscurrent2017 — presentBelgium
Sequana Medical NVMember Board of Directorscurrent2016 — presentBelgium
Fournier-Majoie FoundationMember Board of Directorscurrent2015 — present
HUBMember Board of Directorscurrent2015 — present
reMYND NVMember Board of Directorscurrent2009 — presentBelgium
EMBLEMChairperson of the Supervisory Board2011 — 2022Germany
EMBLEMMember of The Supervisory Board2001 — 2011
Celyad OncologyMember Board of Directors2005 — 2021Belgium
Oncode InstituteCo-founding board member2015 — 2018
Ghent UniversityVisiting Professor2002 — 2012
Multiplicom N.V.Member Board of Directors2010 — 2012Belgium
ActoGeniX N.V.Member Board of Directors2006 — 2012Belgium
FlandersBioCo-founding board member2004 — 2012Belgium
PronotaMember Board of Directors2004 — 2012Belgium
VIBManaging Director1995 — 2012Ghent, Flemish Region, Belgium
AblynxMember Board of Directors2002 — 2007Belgium
AblynxChairperson of the Board2001 — 2002Belgium
CropDesign - a BASF Plant Science CompanyMember Board of Directors1998 — 2006Belgium
DevgenMember Board of Directors1997 — 2000Belgium

Deals · 1

LumeonBoard seat

via EQT Life Sciences · filed Aug 2023 · $12M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at EQT Life Sciences

Alexandra Edlund

Chief People Officer at EQT Life Sciences

Anne Portwich

Partner at EQT Life Sciences

Arno de Wilde

Investor at EQT Life Sciences

Bert Janssens

Partner, Co-Head of Private Capital at EQT Life Sciences

Bruno Holthof

Partner at EQT Life Sciences

Christina Drews

Chief Operating Officer at EQT Life Sciences

Christoph Broja

Partner at EQT Life Sciences

Cillian King

Managing Director at EQT Life Sciences

Network1

Felice Verduyn - Van Weegen

Partner at EQT Life Sciences

Investors connected to Rudy in public investor directories — a warm-intro map.

Frequently asked questions

Who is Rudy Dekeyser?: Head of the Health Economic Funds at EQT Life Sciences and Partner at EQT since 2022; previously a Partner at LSP (2012-2022, which became EQT Life Sciences), Managing Director at VIB in Belgium leading business development, and senior advisor at IWT. Holds a PhD in biotechnology from the University of Ghent.
Where does Rudy Dekeyser work?: Rudy Dekeyser is Partner at EQT Life Sciences.
What does Rudy Dekeyser invest in?: Rudy Dekeyser invests in Biotech.
What check size does Rudy Dekeyser write?: Rudy Dekeyser typically writes checks of $11M – $65M.
What boards does Rudy Dekeyser sit on?: Rudy Dekeyser holds tracked board seats at Lumeon.
Where did Rudy Dekeyser go to school?: Rudy Dekeyser studied at Ghent University (Doctor of Philosophy - PhD, Agriculture Biotechnology).